UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTLS.PRB
6476
DELISTED
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
| $185K | ﹤0.01% |
2,630
+2,619
| +23,809% | +$162K |
|
6477
First Internet Bancorp
INBK
$255M
| $185K | ﹤0.01% |
5,142
+552
| +12% | +$20.9K |
|
|
HTCO
6478
High-Trend International Group
HTCO
$29M
| $185K | ﹤0.01% |
2,221
-60
| -3% | -$2.16K |
|
|
FBLA
6479
FB Bancorp
FBLA
$251M
| $185K | ﹤0.01% |
+15,485
| New | +$188K |
|
|
NUTX
6480
Nutex Health
NUTX
$1.11B
| $184K | ﹤0.01% |
5,822
+4,325
| +289% | +$123K |
|
6481
Achieve Life Sciences
ACHV
$683M
| $184K | ﹤0.01% |
52,342
+36,104
| +222% | +$164K |
|
|
CLPR
6482
Clipper Realty
CLPR
$46.2M
| $184K | ﹤0.01% |
40,219
+26,882
| +202% | +$151K |
|
|
SFHG
6483
Samfine Creation Holdings
SFHG
$9.38M
| $184K | ﹤0.01% |
+30,443
| New | +$1.42M |
|
6484
XBiotech
XBIT
$69.2M
| $184K | ﹤0.01% |
46,531
+32,106
| +223% | +$219K |
|
6485
VanEck Digital India ETF
DGIN
$15.7M
| $184K | ﹤0.01% |
+4,142
| New | +$184K |
|
6486
Franklin Financial Services
FRAF
$280M
| $183K | ﹤0.01% |
6,137
-1,511
| -20% | -$48.3K |
|
|
ONL
6487
Orion Office REIT
ONL
$160M
| $183K | ﹤0.01% |
49,363
-12,805
| -21% | -$50.4K |
|
|
GNTY
6488
DELISTED
Guaranty Bancshares
GNTY
| $183K | ﹤0.01% |
5,287
-2,613
| -33% | -$91.6K |
|
6489
ProShares S&P 500 ex-Technology ETF
SPXT
$288M
| $183K | ﹤0.01% |
1,996
+1,869
| +1,472% | +$173K |
|
|
CRON
6490
Cronos Group
CRON
$1.14B
| $182K | ﹤0.01% |
90,235
+49,090
| +119% | +$102K |
|
6491
Organogenesis Holdings
ORGO
$239M
| $182K | ﹤0.01% |
56,896
-1,943
| -3% | -$6.52K |
|
6492
Utah Medical Products
UTMD
$225M
| $182K | ﹤0.01% |
2,961
+918
| +45% | +$59.3K |
|
6493
KNOT Offshore Partners
KNOP
$366M
| $182K | ﹤0.01% |
33,393
+31,787
| +1,979% | +$192K |
|
6494
Sprott Junior Uranium Miners ETF
URNJ
$356M
| $182K | ﹤0.01% |
9,787
-18,371
| -65% | -$415K |
|
6495
Aptus Behavioral Momentum ETF
ADME
$303M
| $181K | ﹤0.01% |
+3,881
| New | +$183K |
|
|
EEX
6496
DELISTED
Emerald Holding
EEX
| $181K | ﹤0.01% |
37,589
+28,849
| +330% | +$132K |
|
6497
Momentus
MNTS
$92.7M
| $181K | ﹤0.01% |
1,278
+1,021
| +397% | +$143K |
|
|
SCD
6498
LMP Capital and Income Fund
SCD
$358M
| $180K | ﹤0.01% |
10,476
-2,315
| -18% | -$40K |
|
6499
CSP Inc
CSPI
$82.1M
| $180K | ﹤0.01% |
11,187
+10,862
| +3,342% | +$157K |
|
6500
Enanta Pharmaceuticals
ENTA
$400M
| $179K | ﹤0.01% |
31,152
+1,816
| +6% | +$17.4K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.